DOCSLIB.ORG

The Abstract Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Abstract Book PHD DAY HEALTH PROGRAMME & ABSTRACTS 26 JANUARY 2018 PHD DAY 2018 PROGRAMME LOCATION: THE LAKESIDE LECTURE THEATRES 26 JANUARY 2018 8.30 Welcome by the Dean Lars Bo Nielsen, Dean, The Faculty of Health, Aarhus University 8.40 Welcome and presentation of the programme by the chairman of the PHD Association Iben Bach Damgaard, PhD student, Chairman of the PhD Association, Health, AU 8.50 “Believe in Science”, keynote lecture Charles A. Dinarello, Professor of Medicine and Immunology at the University of Colorado School of Medicine, and Professor of Experimental Medicine at Radboud University in the Netherlands. Introduced by Helene Nørrelund, Head of the Graduate School, Health, AU 09.50 Coffee/tea and fruit break 10.15 Poster presentations The Lakeside Lecture Theatres, the Bartholin Building (build. 1241) and Anatomy (build. 1230) 11.45 Lunch /poster viewing The Lakeside Lecture Theatres, the Bartholin Building (build. 1241) and Anatomy (build. 1230) 12.30 Oral presentations The Lakeside Lecture Theatres and the Bartholin Building (build. 1241) 14.00 Break 14.15 “Believe in Science”, keynote lecture Joseph Stephen Alpert, American cardiologist and professor of medicine at the University of Arizona Sarver Heart Center and editor-in-chief of the American Journal of Medicine. Introduced by Helene Nørrelund, Head of the Graduate School, Health, AU 15.15 Coffee/tea and cake break 15.40 Fogh-Nielsen Competition Chaired by Professor Søren K. Moestrup, Chairman of the Fogh-Nielsen board and co-chairman Rasmus Pihl, PhD student, Health, AU 16.25 Awards, Posters and oral presentations Professor, Bent Winding Deleuran and PhD student, Rasmus Pihl, Chair and Co-chair of the Organizing Committee, PhD Day 2018 16.35 Closing remarks Helene Nørrelund, Head of the Graduate School, Health, AU 16.40 The programme for the day ends 18.30 Dinner and awards ceremony for the JCD prize and the Fogh-Nielsen Competition Centralværkstedet; Aarhus C. Festive speech Pil Lindgreen, PhD student, Health, AU Aarhus University Graduate School of Health PHD DAY 26 JANUARY 2018 1 Practical Information • Posters should be hung up between 16:30 and 19:00 on 25 January or between 7:30 and 8:00 on 26 January. Posters may be removed from 12:30 on 26 January 2018. Posters that have not been removed at 15.15 will be placed near the reception desk in The Lakeside Lecture Theatres and can be collected after conclusion of the scientific programme of the PhD day • Oral presenters for sessions O1-O5 must meet in the auditorium concerned between 7:30 and 8:00 on 26 January to save their presentation onto the auditorium hard disk • Lunch is served at the Lakeside Lecture Theatre and at the poster viewing areas in the Bartholin Building and at Anatomy Oral session 1: Lakeside Lecture Theatres, Per Kirkeby Auditorium Oral session 2: Lakeside Lecture Theatres, Merethe Barker Auditorium Oral session 3: Lakeside Lecture Theatres, Eduard Biermann Auditorium Oral session 4: Lakeside Lecture Theatres, Jeppe Vontilius Auditorium Oral session 5: Bartholin building, Auditorium 1 Poster session 1-6: Lakeside Lecture Theatres, William Scharff Auditorium Poster session 7-22: Bartholin building, (building: 1240-1241) Auditorium 2, 3, 4, Studyroom, Gardenroom, room 130 and halls Poster session 23-29: Anatomy, (building 1230-1231): Hall and Colloquium room 1 Organizing committee for PhD Day 2018: • Bent Deleuran, Professor, Department of Biomedicine, Chairman • Rasmus Pihl, PhD student, Department of Biomedicine, Co-chairman • Helle Mellerup, PhD Administration • Johan Palmfeldt, Associate professor, Department of Clinical Medicine • Khoa Manh Dinh, PhD student, Department of Clinical Medicine • Louise Hauge Matzen, Associate professor, Department of Dentistry and Oral Health • Martin Nors Skov, PhD student, Department of Clinical Medicine • Pernille Thomasen, PhD student, Department of Biomedicine • Rasmus Bysted Møller, Assistant professor, Department of Public Health - Sport Science • Sashia Bak-Nielsen, PhD student, Department of Clinical Medicine • Simin Berenji Ardestani, PhD student, Department of Clinical Medicine • Stine Andersen, PhD student, Department of Clinical Medicine • Terkel Rørkær Sigh, PhD Administration • Trine Wigh Arildskov, PhD student, Department of Clinical Medicine • Ulla Kampmann Opstrup, Postdoc, Department of Clinical Medicine Social media: • Facebook: PhD Association Health • Instagram: #auhealthphdday Lakeside Lecture Theatres Merethe Barker Oral 2 E. Biermann Oral 3 Level 2 Foyer William Scharff Poster session J. Vontillius 1-6 Oral 4 Level 3 Per Kirkeby Main Venue Oral 1 Level 4 Bartholin Building (building: 1240/1241) • Oral 5 • Poster session 7-22 Anatomy (building 1230/1231) • Poster session 23-29 Practical Information Session overview: Oral session 1: Lakeside Lecture Theatres, Per Kirkeby Auditorium Oral session 2: Lakeside Lecture Theatres, Merethe Barker Auditorium Oral session 3: Lakeside Lecture Theatres, Eduard Biermann Auditorium Oral session 4: Lakeside Lecture Theatres, Jeppe Vontilius Auditorium Oral session 5: Bartholin building (building: 1241/135), Auditorium 1 Poster session 1-6: Lakeside Lecture Theatres, William Scharff Auditorium Poster session 7-11: Bartholin building, (building: 1241/211), Studyroom, (First floor) Poster session 12: Bartholin building, (building: 1241/231), Gardenroom, (First floor) Poster session 13: Bartholin building, (building: 1240-41), Hall (First floor) Poster session 14-15: Bartholin building, (building: 1241/125+129), Auditorium 2 Poster session 16-17: Bartholin building, (building: 1241/119), Auditorium 3 Poster session 18-19: Bartholin building, (building: 1241/114), Auditorium 4 Poster session 20-21: Bartholin building, (building: 1240-41), Hall (Ground floor, at Aud.1) Poster session 22: Bartholin building, (building: 1240-41), Room 130 (Ground floor) Poster session 23-26: Anatomy (building 1231/114), Colloquium room 1 Poster session 27-29: Anatomy (building 1230), Hall Believe in Science On behalf of the PhD Association, the Graduate School of Health, Aarhus University and this year’s Organizing Committee, we welcome all students, faculty members and distinguished guests to the PhD Day 2018 You are invited to enjoy five oral and 29 poster sessions as well as the Fogh Nielsen Competition. This year’s topic aims to inspire you to venture outside your comfort zone in pursuit of new insights within your research field. By balancing Methodological rigor with creative imagination, you are encouraged to make all of us believe in science by opening new pathways to better treatment. This year we have two keynote speakers: Professor Charles A. Dinarello from University of Colorado, USA and Radboud University in the Netherlands and Professor Joseph S. Alpert from University of Arizona, USA. Charles A. Dinarello will give you an outstanding perspective on how groundbreaking scientific discoveries can be put into valuable therapeutic use. He is considered one of the founding fathers of cytokines and has -received numerous awards and prizes for his contribution to the field of cytokines and medicine. He is regarded as one of the most influential biomedical researchers of our time and has been granted honorary degrees from various Universities around the world. Joseph S. Alpert is a Danish-American cardiologist and editor-in-chief of the American Journal of Medicine. He is an honorary member of scientific societies in Denmark, Israel and Argentina and has received many awards for excellence in teaching. Prepare for a thrilling lecture on the importance of science in todays society. By the end of the day we hope that our firm belief in science have been passionately revitalized by the new original ideas and perspectives presented. Finally, a warm thank you to everybody who has participated and helped to make the PhD day 2018 a – hopefully – joyful and inspiring event. Bent Deleuran, Professor Rasmus Pihl, PhD student Chairman of the Organizing Committee Co-Chairman of the Organizing Committee Health, Aarhus University Health, Aarhus University Lars Bo Nielsen Lise Wogensen Bach Dean Vice-dean Health, Aarhus University Health, Aarhus University Helene Nørrelund Head of Graduate School Health, Aarhus University The Keynote Lecture Charles A. Dinarello, Professor of Medicine and Immunology Charles A. Dinarello is Professor of Medicine and Immunology at the University of Colorado School of Medicine and Professor of Experimental Medicine at Radboud University in the Netherlands. He received his medical degree from Yale University, clinical training at the Massachusetts General Hospital and from 1971-77, he was at the National Institutes of Health in Bethesda. Dr. Dinarello is considered one of the founding fathers of cytokines. He was the first to purify interleukin-1 (IL-1) in 1977 and identified IL-1 in 1974. His group reported the first cDNA for IL-1 in 1984. He has published over 700 original research articles and 250 reviews and book chapters on inflammatory cytokines, particularly on IL-1, the IL-1 family and related cytokines. He has trained over 50 investigators, many of whom are recognized experts in their fields. The Institute for Scientific Information listed Dinarello as the world's 4th most-cited scientist during the 20 years 1983-2002 and from 1996 to 2011, he was listed as one of 400 of the world’s most influential biomedical researchers. In 1998, Dinarello was elected to the United States National Academy of Sciences and in 2010, he was made a foreign member of the Royal Netherlands Academy of Sciences.
Load more

Recommended publications
  • Iran Human Rights Defenders Report 2019/20
    IRAN HUMAN RIGHTS DEFENDERS REPORT 2019/20 Table of Contents Definition of terms and concepts 4 Introduction 7 LAWYERS Amirsalar Davoudi 9 Payam Derafshan 10 Mohammad Najafi 11 Nasrin Sotoudeh 12 CIVIL ACTIVISTS Zartosht Ahmadi-Ragheb 13 Rezvaneh Ahmad-Khanbeigi 14 Shahnaz Akmali 15 Atena Daemi 16 Golrokh Ebrahimi-Irayi 17 Farhad Meysami 18 Narges Mohammadi 19 Mohammad Nourizad 20 Arsham Rezaii 21 Arash Sadeghi 22 Saeed Shirzad 23 Imam Ali Popular Student Relief Society 24 TEACHERS Esmaeil Abdi 26 Mahmoud Beheshti-Langroudi 27 Mohammad Habibi 28 MINORITY RIGHTS ACTIVISTS Mary Mohammadi 29 Zara Mohammadi 30 ENVIRONMENTAL ACTIVISTS Persian Wildlife Heritage Foundation 31 Workers rights ACTIVISTS Marzieh Amiri 32 This report has been prepared by Iran Human Rights (IHR) Esmaeil Bakhshi 33 Sepideh Gholiyan 34 Leila Hosseinzadeh 35 IHR is an independent non-partisan NGO based in Norway. Abolition of the Nasrin Javadi 36 death penalty, supporting human rights defenders and promoting the rule of law Asal Mohammadi 37 constitute the core of IHR’s activities. Neda Naji 38 Atefeh Rangriz 39 Design and layout: L Tarighi Hassan Saeedi 40 © Iran Human Rights, 2020 Rasoul Taleb-Moghaddam 41 WOMEN’S RIGHTS ACTIVISTS Raha Ahmadi 42 Raheleh Ahmadi 43 Monireh Arabshahi 44 Yasaman Aryani 45 Mojgan Keshavarz 46 Saba Kordafshari 47 Nedaye Zanan Iran 48 www.iranhr.net Recommendations 49 Endnotes 50 : @IHRights | : @iranhumanrights | : @humanrightsiran Definition of Terms & Concepts PRISONS Evin Prison: Iran’s most notorious prison where Wards 209, 240 and 241, which have solitary cells called security“suites” and are controlled by the Ministry of Intelligence (MOIS): Ward 209 Evin: dedicated to security prisoners under the jurisdiction of the MOIS.
    [Show full text]
  • Prepared Testimony to the United States Senate Foreign Relations
    Prepared Testimony to the United States Senate Foreign Relations Subcommittee on Near Eastern and South and Central Asian Affairs May 11, 2011 HUMAN RIGHTS AND DEMOCRATIC REFORM IN IRAN Andrew Apostolou, Freedom House Chairman Casey, Ranking member Risch, Members of the Subcommittee, it is an honour to be invited to address you and to represent Freedom House. Please allow me to thank you and your staff for all your efforts to advance the cause of human rights and democracy in Iran. It is also a great pleasure to be here with Rudi Bakhtiar and Kambiz Hosseini. They are leaders in how we communicate the human rights issue, both to Iran and to the rest of the world. Freedom House is celebrating its 70th anniversary. We were founded on the eve of the United States‟ entry into World War II by Eleanor Roosevelt and Wendell Wilkie to act as an ideological counterweight to the Nazi‟s anti-democratic ideology. The Nazi headquarters in Munich was known as the Braunes Haus, so Roosevelt and Wilkie founded Freedom House in response. The ruins of the Braunes Haus are now a memorial. Freedom House is actively promoting democracy and freedom around the world. The Second World War context of our foundation is relevant to our Iran work. The Iranian state despises liberal democracy, routinely violates human rights norms through its domestic repression, mocks and denies the Holocaust. Given the threat that the Iranian state poses to its own population and to the Middle East, we regard Iran as an institutional priority. In addition to Freedom House‟s well-known analyses on the state of freedom in the world and our advocacy for democracy, we support democratic activists in some of the world‟s most repressive societies, including Iran.
    [Show full text]
  • Iran 2019 Human Rights Report
    IRAN 2019 HUMAN RIGHTS REPORT EXECUTIVE SUMMARY The Islamic Republic of Iran is an authoritarian theocratic republic with a Shia Islamic political system based on velayat-e faqih (guardianship of the jurist). Shia clergy, most notably the rahbar (supreme leader), and political leaders vetted by the clergy dominate key power structures. The supreme leader is the head of state. The members of the Assembly of Experts are nominally directly elected in popular elections. The assembly selects and may dismiss the supreme leader. The candidates for the Assembly of Experts, however, are vetted by the Guardian Council (see below) and are therefore selected indirectly by the supreme leader himself. Ayatollah Ali Khamenei has held the position since 1989. He has direct or indirect control over the legislative and executive branches of government through unelected councils under his authority. The supreme leader holds constitutional authority over the judiciary, government-run media, and other key institutions. While mechanisms for popular election exist for the president, who is head of government, and for the Islamic Consultative Assembly (parliament or majles), the unelected Guardian Council vets candidates, routinely disqualifying them based on political or other considerations, and controls the election process. The supreme leader appoints half of the 12-member Guardian Council, while the head of the judiciary (who is appointed by the supreme leader) appoints the other half. Parliamentary elections held in 2016 and presidential elections held in 2017 were not considered free and fair. The supreme leader holds ultimate authority over all security agencies. Several agencies share responsibility for law enforcement and maintaining order, including the Ministry of Intelligence and Security and law enforcement forces under the Interior Ministry, which report to the president, and the Islamic Revolutionary Guard Corps (IRGC), which reports directly to the supreme leader.
    [Show full text]
  • Download Full Text
    Annual Report 2019 Published March 2019 Copyright©2019 The Women’s Committee of the National Council of Resistance of Iran (NCRI) All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of the publisher, nor be otherwise circulated in any form of binding or cover other than that in which it is published and without a similar condition including this condition being imposed on the subsequent purchaser. ISBN: 978- 2 - 35822 - 010 -1 women.ncr-iran.org @womenncri @womenncri Annual Report 2018-2019 Foreword ast year, as we were preparing our Annual Report, Iran was going through a Table of Contents massive outbreak of protests which quickly spread to some 160 cities across the Lcountry. One year on, daily protests and nationwide uprisings have turned into a regular trend, 1 Foreword changing the face of an oppressed nation to an arisen people crying out for freedom and regime change in all four corners of the country. Iranian women also stepped up their participation in protests. They took to the streets at 2 Women Lead Iran Protests every opportunity. Compared to 436 protests last year, they participated in some 1,500 pickets, strikes, sit-ins, rallies and marches to demand their own and their people’s rights. 8 Women Political Prisoners, Strong and Steady Iranian women of all ages and all walks of life, young students and retired teachers, nurses and farmers, villagers and plundered investors, all took to the streets and cried 14 State-sponsored Violence Against Women in Iran out for freedom and demanded their rights.
    [Show full text]
  • The Role of 18F-Flortaucipir (AV-1451) in the Diagnosis of Neurodegenerative Disorders
    Open Access Review Article DOI: 10.7759/cureus.16644 The Role of 18F-Flortaucipir (AV-1451) in the Diagnosis of Neurodegenerative Disorders Saswata Roy 1 , Dipanjan Banerjee 2, 3 , Indrajit Chatterjee 4 , Deepika Natarajan 5 , Christopher Joy Mathew 2 1. General Medicine, Musgrove Park Hospital, Taunton, GBR 2. Internal Medicine, East Sussex Healthcare NHS Trust, Hastings, GBR 3. Neuroscience, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA 4. General Psychiatry, Wishaw University Hospital, Hamilton, GBR 5. General Surgery, North Cumbria Integrated Care (NCIC), Carlisle, GBR Corresponding author: Saswata Roy, [email protected] Abstract Tau protein plays a vital role in maintaining the structural and functional integrity of the nervous system; however, hyperphosphorylation or abnormal phosphorylation of tau protein plays an essential role in the pathogenesis of several neurodegenerative disorders. The development of radioligand such as the 18F- flortaucipir (AV-1451) has provided us with the opportunity to assess the underlying tau pathology in various etiologies of dementia. For the purpose of this article, we aimed to evaluate the utility of 18F-AV- 1451 in the differential diagnosis of various neurodegenerative disorders. We used PubMed to look for the latest, peer-reviewed, and informative articles. The scope of discussion included the role of 18F-AV-1451 positron emission tomography (PET) to aid in the diagnosis of Alzheimer’s disease (AD), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), and Parkinson’s disease with dementia (PDD). We also discussed if the tau burden identified by neuroimaging correlated well with the clinical severity and identified the various challenges of 18F-AV-1451 PET.
    [Show full text]
  • And Second- Generation of Afghan Immigrants Residing in Iran: a Case Study of Southeast of Tehran
    35 Journal of Geography and Spatial Justice .Year 1th - Vol.1 – No 1, Winter2018, pp: 35-44 University of Mohaghegh Ardabili Journal of Geography and Spatial Justice Received:2018/01/05 accepted:2018/03/05 A comparative study of the quality of urban life between the first- and second- generation of Afghan immigrants residing in Iran: A case study of southeast of Tehran Saeed Zanganeh Shahraki *1, Hossein HatamiNejad 2, Yaghob Abdali 3, Vahid Abbasi Fallah 4 1 Assistant Professor, Department of Geography and Urban Planning, University of Tehran, Tehran, Iran. 2 Associate Professor, Department of Geography and Urban Planning, University of Tehran, Tehran, Iran. 3 Ph.D. Student, Department of Geography and Urban Planning, University of Tehran, Tehran, Iran. 4 Ph.D. Student, Department of Geography and Urban Planning, University of Tehran, Tehran, Iran * Corresponding Author, Email: [email protected] A B S T R A C T Islamic Republic of Iran hosts the largest refugee populations in the world. According to the statistics officially announced in 2007, there are 1,025,000 refugees in Iran, among whom 940,400 refugees are Afghan and 54,400 refugees are Iraqi. After a period of settling and living in the host community, changes begin to occur in the immigrants' quality of life over time and the lives of the second generation of immigrants undergo greater changes than those of the first generation. The present study aims to explore the differences between the two groups of first- and second- generation of Afghan refugees living in Iran in terms of their quality of life in general and their job quality in particular.
    [Show full text]
  • Migrations and Social Mobility in Greater Tehran: from Ethnic Coexistence to Political Divisions?
    Migrations and social mobility in greater Tehran : from ethnic coexistence to political divisions? Bernard Hourcade To cite this version: Bernard Hourcade. Migrations and social mobility in greater Tehran : from ethnic coexistence to political divisions?. KUROKI Hidemitsu. Human mobility and multi-ethnic coexistence in Middle Eastern Urban societies1. Tehran Aleppo, Istanbul and Beirut. , 102, Research Institute for languages and cultures of Asia and Africa, Tokyo University of Foreign Languages, pp.27-40, 2015, Studia Culturae Islamicae, 978-4-86337-200-9. hal-01242641 HAL Id: hal-01242641 https://hal.archives-ouvertes.fr/hal-01242641 Submitted on 13 Dec 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. LIST OF CONTRIBUTORS Bernard Hourcade is specializing in geography of Iran and Research Director Emeritus of Le Centre national de la recherche scientifique. His publication includes L'Iran au 20e siècle : entre nationalisme, islam et mondialisation (Paris: Fayard, 2007). Aïda Kanafani-Zahar is specializing in Anthropology and Research Fellow of Le Centre national de la recherche scientifique, affiliating to Collège de France. Her publication includes Liban: le vivre ensemble. Hsoun, 1994-2000 (Paris: Librairie Orientaliste Paul Geuthner, 2004). Stefan Knost is specializing in Ottoman history of Syria and Acting Professor of Martin-Luther-Universität Halle-Wittenberg.
    [Show full text]
  • Report of the Special Rapporteur on the Situation of Human Rights in the Islamic Republic of Iran, Ahmed Shaheed*,**
    A/HRC/28/70 Advance Unedited Version Distr.: General 12 March 2015 Original: English Human Rights Council Twenty-eighth session Agenda item 4 Human rights situations that require the Council’s attention Report of the Special Rapporteur on the situation of human rights in the Islamic Republic of Iran, Ahmed Shaheed*,** Summary In the present report, the fourth to be submitted to the Human Rights Council pursuant to Council resolution 25/24, the Special Rapporteur highlights developments in the situation of human rights in the Islamic Republic of Iran since his fourth interim report submitted to the General Assembly (A/68/503) in October 2013. The report examines ongoing concerns and emerging developments in the State’s human rights situation. Although the report is not exhaustive, it provides a picture of the prevailing situation as observed in the reports submitted to and examined by the Special Rapporteur. In particular, and in view of the forthcoming adoption of the second Universal Periodic Review of the Islamic Republic of Iran, it analysis these in light of the recommendations made during the UPR process. * Late submission. ** The annexes to the present report are circulated as received, in the language of submission only. GE.15- A/HRC/28/70 Contents Paragraphs Page I. Introduction ............................................................................................................. 1-5 3 II. Methodology ........................................................................................................... 6-7 4 III. Cooperation
    [Show full text]
  • Tauvid Integrated Review Document
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 212123Orig1s000 INTEGRATED REVIEW Executive Summary Interdisciplinary Assessment Appendices NDA212123 Tauvid (flortaucipir F 18 injection) Integrated Review Table 1. Administrative Application Information Category Application Information Application type NDA Application number{s) 212123 Priority or standard Ptiority Submit date{s) 9/30/2019 Received date(s) 9/30/2019 PDUFA goal date 5/29/2020 Division/office Division oflmaging and Radiation Medicine (DIRM) Review completion date 5/27/2020 Established name Flo1taucipir F 18 (Proposed) trade name Tauvid Pharmacologic class Radioactive diagnostic agent (for PET imaging) Code name F18-AV-1451 , F18-T807, LSN3182568 Applicant Avid Radiopha1maceuticals Inc Dose form/formulation(s) Injection Dosing regimen 370 MBq (10 mCi), administered as a bolus intravenous injection Applicant proposed For positron emission tomography (PET) imaging ofthe brain to indication{s)/population{s) estimate the density and disttibution of ag~gated tau 4 nemofibrillary tangles (NFTs) !b>T m adult oatients who are bein~evaluat~d for AD (b)(4__<l>H_ •l Proposed SNOMED indication Regulatory action Approval Approved Tauvid is indicated for use with PET imaging of the brain to indication{s)/population{s) estimate the density and disttibution of aggregated tau NFTs in {if applicable) adult patients with cognitive impaiiment who are being evaluated for AD. Limitations ofUse: Tauvid is not indicated for use in the evaluation ofpatients for chronic traumatic encephalopathy (CTE) Approved SNOMED 386806002 Ihnpaired cognition (fmdiI1g) indication Integrated Review Template, version date 2019/09/25 Reference ID: 4615642 NDA212123 Tauvid (flortaucipir F 18 injection) Table of Contents Table ofTables ....................................................................................................................v Table ofFigures ...............................................................................................................
    [Show full text]
  • Neuroimaging of Alzheimer's Disease: Focus on Amyloid and Tau
    Japanese Journal of Radiology (2019) 37:735–749 https://doi.org/10.1007/s11604-019-00867-7 INVITED REVIEW Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET Hiroshi Matsuda1 · Yoko Shigemoto2 · Noriko Sato2 Received: 23 July 2019 / Accepted: 28 August 2019 / Published online: 6 September 2019 © Japan Radiological Society 2019 Abstract Although the diagnosis of dementia is still largely a clinical one, based on history and disease course, neuroimaging has dra- matically increased our ability to accurately diagnose it. Neuroimaging modalities now play a wider role in dementia beyond their traditional role of excluding neurosurgical lesions and are recommended in most clinical guidelines for dementia. In addition, new neuroimaging methods facilitate the diagnosis of most neurodegenerative conditions after symptom onset and show diagnostic promise even in the very early or presymptomatic phases of some diseases. In the case of Alzheimer’s disease (AD), extracellular amyloid-β (Aβ) aggregates and intracellular tau neurofbrillary tangles are the two neuropathological hallmarks of the disease. Recent molecular imaging techniques using amyloid and tau PET ligands have led to preclinical diagnosis and improved diferential diagnosis as well as narrowed subject selection and treatment monitoring in clinical trials aimed at delaying or preventing the symptomatic phase of AD. This review discusses the recent progress in amyloid and tau PET imaging and the key fndings achieved by the use of this molecular imaging modality related to the respective roles of Aβ and tau in AD, as well as its specifc limitations. Keywords Dementia · Alzheimer’s disease · PET · Amyloid · Tau Introduction expected to reach 7 million in 2025, representing approxi- mately one in fve elderly people in Japan [3].
    [Show full text]
  • Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
    THE STATE OF THE ART Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy Richard L. Wahl1, Panithaya Chareonthaitawee2, Bonnie Clarke3, Alexander Drzezga4, Liza Lindenberg5, Arman Rahmim6, James Thackeray7, Gary A. Ulaner8, Wolfgang Weber9, Katherine Zukotynski10, and John Sunderland11 1Mallinckrodt Institute of Radiology, Washington University St. Louis, Missouri; 2Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; 3Research and Discovery, Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia; 4Department of Nuclear Medicine, University of Cologne, Cologne, Germany, German Center for Neurodegenerative Diseases, Bonn- Cologne, Germany, and Institute of Neuroscience and Medicine, Molecular Organization of the Brain, Forschungszentrum J¨ulich, J¨ulich, Germany; 5Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; 6Departments of Radiology and Physics, University of British Columbia, Vancouver, British Columbia, Canada; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada; 7Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; 8Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, and Molecular Imaging and Therapy, Hoag Cancer Center, Newport Beach, California; 9Department of Nuclear Medicine, Technical University Munich, Munich, Germany; 10Departments of Medicine and Radiology,
    [Show full text]
  • Phd Day 2015 Programme
    PHD DAY 2015 PROGRAMME 8.30 Welcome Professor Lise Wogensen Bach, Vice dean and Head of Graduate School 8.40 Welcome and today’s program Alexander Juhl Andersen, Co-chairman of the PhD Association 8.45 Fogh-Nielsen Prize competition Chaired by Professor Søren Moestrup, chairman of the Fogh-Nielsen board 9.30 Coffee/tea and fruit break The Lakeside auditorium 9.45 Oral presentations The Lakeside auditorium 11.15 Break 11.30 Poster presentations Bartholin (build. 1241), Anatomy (build. 1230) and the Lakeside Auditorium 12.45 Lunch /poster viewing Bartholin (build. 1241), Anatomy (build. 1230) and the Lakeside Auditorium 13.30 “Academic doping”, panel debate Panel participants: Professor Kirsten Ohm Kyvik , Professor Jørgen Frøkiær Associate Professor Ask Vest Christiansen and Professor Eskild Petersen 15.00 Coffee/tea and cake break The Lakeside auditorium 15.15 “Diligence, Deception and Fraud”, key note lecture Morten Staberg, Pediatric specialist, MD 16.00 Poster and oral awards The Lakeside Auditorium 16.45 Closing remarks Professor Lise Wogensen Bach, Vice dean and Head of Graduate School 18.30 Dinner and awards ceremony for the JCD and the Fogh Nielsen prizes Centralværkstedet Festive speech by Professor Ole Bækgaard Nielsen AARHUS UNIVERSITY Aarhus University Graduate School of Health PHD DAY 23 JANUARY 2015 1 Practical Information nd Posters should be hung up between 4.30pm and 8pm on January 22 or between 7.30am and 8am on January 23rd. All posters must be taken down before 3.00 pm Oral presenters for sessions O1-O5 must meet in the auditorium concerned between 7.30am and 8:00am on January 23rd to save their presentation onto the auditorium hard disk.
    [Show full text]